Flumazenil: Potential implications for hepatic encephalopathy
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 45 (3) , 331-343
- https://doi.org/10.1016/0163-7258(90)90070-i
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- GABAA Receptor Complex in an Experimental Model of Hepatic Encephalopathy: Evidence for Elevated Levels of an Endogenous Benzodiazepine Receptor LigandJournal of Neurochemistry, 1989
- Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humansGastroenterology, 1989
- REVERSAL OF HEPATIC COMA WITH FLUMAZENIL WITH IMPROVEMENT IN VISUAL EVOKED POTENTIALSThe Lancet, 1988
- Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathyJournal of Neuroscience, 1988
- FlumazenilDrugs, 1988
- Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failureGastroenterology, 1987
- Mechanism of anion permeation through channels gated by glycine and gamma‐aminobutyric acid in mouse cultured spinal neurones.The Journal of Physiology, 1987
- A proposed therapy for the encephalopathies of Reye's Syndrome and Hepatic EncephalopathyMedical Hypotheses, 1984
- Interaction of Convulsive Ligands with Benzodiazepine ReceptorsScience, 1982
- Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effectsPsychopharmacology, 1982